CN103142974B - Medicament for treating anxiety disorder - Google Patents
Medicament for treating anxiety disorder Download PDFInfo
- Publication number
- CN103142974B CN103142974B CN201310108409.0A CN201310108409A CN103142974B CN 103142974 B CN103142974 B CN 103142974B CN 201310108409 A CN201310108409 A CN 201310108409A CN 103142974 B CN103142974 B CN 103142974B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- fructus
- folium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating anxiety disorder. The medicament is prepared from the following substances in parts by weight of 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of radix angelicae, 5-15 parts of inula flower, 10-30 parts of seed of cowherb, 1-15 parts of peach kernel, 10-20 parts of radices sileris, 15-30 parts of oriental wormwood, 20-30 parts of fructus terminaliae billericae, 10-20 parts of scutellaria baicalensis, 1-20 parts of celandine, 10-25 parts of folium mori, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of kaladana, 15-20 parts of herba inulae, 15-20 parts of herb of glabrous sarcandra, 10-20 parts of clinopodium polycephalum, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of root of kudzu vine, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of chinese lantern-plant, 15-25 parts of root bark of white mulberry, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon fruit and 10-25 parts of chinese azalea flower. All components of the medicament for treating the anxiety disorder disclosed by the invention are natural materials; and the medicament is good in security, definite in curative effect, and suitable for large-scale clinical popularization.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of anxiety neurosis.
Background technology
Anxiety neurosis claims again anxiety neurosis, it be take persistence nervous worry, frightened or ictal in terror as the dysthymic disorder of feature, with autonomic nervous system symptom and the uneasy behavior characteristics that waits of motion.The anxiety that anxiety patient shows or fear are not often inconsistent without flesh and blood or with real situation.Doctor trained in Western medicine is mainly used pharmaceutical intervention to the treatment of primary disease at present, but existing medicine Existence dependency, onset slowly, the problems such as untoward reaction.
Summary of the invention
The object of this invention is to provide a kind of medicament for the treatment of anxiety neurosis.
In order to realize object of the present invention, the invention provides a kind of medicament for the treatment of anxiety neurosis, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Semen Persicae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Artemisiae Scopariae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Scutellariae 1-20 part, Herba Chelidonii 1-20 part, Folium Mori 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Puerariae 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
Preferably, the medicament for the treatment of anxiety neurosis of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts, Semen Persicae, 17 parts of Radix Saposhnikoviaes, 24 parts of Herba Artemisiae Scopariaes, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Scutellariaes, 17 parts of Herba Chelidoniis, 23 parts, Folium Mori, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Puerariaes, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of anxiety neurosis of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Below by embodiment, further illustrate the present invention.It should be understood that embodiments of the invention are for the present invention rather than limitation of the present invention are described.The simple modifications that essence according to the present invention is carried out the present invention all belongs to the scope of protection of present invention.Except as otherwise noted, the percent otherwise in the present invention is percetage by weight.
Embodiment decoction of the present invention
Take 7 grams of Radix Scrophulariaes, 13 grams of Rhizoma Zingiberiss, 22 grams of Fructus Corni, 15 grams of Radix Platycodoniss, 21 grams of the Radixs Angelicae Dahuricae, 13 grams of Flos Inulaes, 28 grams of Semen Vaccariae, 11 grams, Semen Persicae, 17 grams of Radix Saposhnikoviaes, 24 grams of Herba Artemisiae Scopariaes, 27 grams of Fructus Terminaliae Billericaees, 18 grams of Radix Scutellariaes, 17 grams of Herba Chelidoniis, 23 grams, Folium Mori, 21 grams of Fructus Xanthii, 16 grams of Fructus Phyllanthis, 16 grams of Folium Et Cacumen Murrayae, 17 grams of Semen Pharbitidiss, 19 grams of Herba Inulae, 15 grams of Herba Sarcandraes, 14 grams of Herba Clinopodii, 21 grams of Folium Sennae, 11 grams of Radix seu Herba Gei aleppici, 13 grams of Radix Puerariaes, 23 grams of Folium Rhododendri Daurici, 24 grams of Herba Potentillae Discoloris, 14 grams of Calyx Seu Fructus Physaliss, 25 grams of Cortex Mori, 26 grams of Herba Eupatorii Lindleyanis, 24 grams of 16 grams of Semen Euryaless and Flos Rhododendri Mollis, add 2000 milliliters, water, in the flask that condensing tube is housed, at 80 ℃, heat 4 hours, filter.Filtrate is concentrated into 600 milliliters, obtains decoction of the present invention.
Experimental example
This group of clinical data case 60 examples, wherein male 30 examples, female's 30 examples; 22～48 years old age, average 33 years old.Diagnostic criteria with reference to the diagnostic criteria of CCMD-3 anxiety neurosis (psychiatric department branch of Chinese Medical Association. Chinese Spirit Obstacles classification and diagnostic criteria [M] the 3rd edition. Jinan: the 2001:103 of Shandong science tech publishing house), disease is seen depressed and discontented disgruntled, depression of liver-QI, sorrow is pondered over, dysfunction of the spleen in transportation.
Use the decoction of preparing in embodiment to treat, every day 2 times, each oral 50 milliliters.Treating 2 months is 1 course for the treatment of.
Criterion of therapeutical effect is evaluated by the traditional Chinese medical science disease Standardization of diagnosis and curative effect of Chinese combination of Chinese and Western medicine mental sickness Professional Committee of association revision in 1991.Recovery from illness: transference cure, emotion is only normal; Take a turn for the better: symptom alleviates, and emotion is basicly stable; Invalid: symptom, emotion are not all obviously improved.
Through the treatment of a course for the treatment of, finding that there is 60 patient treatment effects is all recovery from illness, and during whole treatment, does not observe obvious untoward reaction.
In treatment, all patient is followed up a case by regular visits to weekly after a course for the treatment of, continue half a year, find the sign of recurrence.
Claims (2)
1. treat the medicament of anxiety neurosis for one kind, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Semen Persicae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Artemisiae Scopariae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Scutellariae 1-20 part, Herba Chelidonii 1-20 part, Folium Mori 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Semen Pharbitidis 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Puerariae 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament for the treatment of anxiety neurosis according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts, Semen Persicae, 17 parts of Radix Saposhnikoviaes, 24 parts of Herba Artemisiae Scopariaes, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Scutellariaes, 17 parts of Herba Chelidoniis, 23 parts, Folium Mori, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of Semen Pharbitidiss, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Puerariaes, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rhododendri Mollis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310108409.0A CN103142974B (en) | 2013-03-22 | 2013-03-22 | Medicament for treating anxiety disorder |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310108409.0A CN103142974B (en) | 2013-03-22 | 2013-03-22 | Medicament for treating anxiety disorder |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103142974A CN103142974A (en) | 2013-06-12 |
| CN103142974B true CN103142974B (en) | 2014-04-30 |
Family
ID=48541483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310108409.0A Expired - Fee Related CN103142974B (en) | 2013-03-22 | 2013-03-22 | Medicament for treating anxiety disorder |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103142974B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103520438B (en) * | 2013-10-17 | 2015-04-01 | 王刚 | Oral liquid for relieving anxiety of students during teaching |
| CN104138537A (en) * | 2014-05-21 | 2014-11-12 | 吴红霞 | Oral medicine preparation for treating anxiety |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1121811A (en) * | 1994-05-12 | 1996-05-08 | 广东医学院医药科技开发中心 | Drug prescription for treatment of neurosis and preparing method thereof |
-
2013
- 2013-03-22 CN CN201310108409.0A patent/CN103142974B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1121811A (en) * | 1994-05-12 | 1996-05-08 | 广东医学院医药科技开发中心 | Drug prescription for treatment of neurosis and preparing method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103142974A (en) | 2013-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103157087A (en) | Drug for treating femoral head necrosis | |
| CN103142974B (en) | Medicament for treating anxiety disorder | |
| CN103142982A (en) | Medicine for treating acute upper respiratory infection | |
| CN103142959A (en) | Medicament for treating urticaria | |
| CN103142987B (en) | Medicament for treating mumps | |
| CN103142981A (en) | Medicament for treating mammitis | |
| CN101537148A (en) | External application drug for curing eczema and preparation method thereof | |
| CN102716419B (en) | Compound oral liquid for developing intelligence and tonifying kidneys | |
| CN103142972B (en) | Medicine for treating children dermatosis | |
| CN103157084A (en) | Drug for treating osteoporosis | |
| CN103157090A (en) | Medicament for treating diarrhea | |
| CN103142954A (en) | Medicine for treating asthma | |
| CN103893601A (en) | Medicament for treating epidemic parotitis | |
| CN103272192B (en) | Medicament for treating perianal abscess | |
| CN103157092A (en) | Drug for treating schizophrenia | |
| CN103142960B (en) | Medicament for treating skin diseases | |
| CN103142973B (en) | Medicament for treating neurasthenia | |
| CN103142969A (en) | Medicament for treating dysthymia | |
| CN103142977A (en) | Medicament for treating dysmenorrhea | |
| CN103142955A (en) | Medicine for treating cold | |
| CN103495013B (en) | Medicament for treating anxiety disorder in psychiatric nursing | |
| CN103301297B (en) | Pharmaceutical composition for treating diarrhea of children induced by fright | |
| CN103142984B (en) | Medicine for treating rheumatism | |
| CN103157083A (en) | Medicament for treating premature beat | |
| CN103203007B (en) | Medicament used for treating bedsore in clinical care |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHANG YONG Free format text: FORMER OWNER: XU DAOHUI Effective date: 20140328 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zhang Yong Inventor before: Xu Daohui |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: XU DAOHUI TO: ZHANG YONG Free format text: CORRECT: ADDRESS; FROM: 272699 JINING, SHANDONG PROVINCE TO: 272100 JINING, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140328 Address after: Department of Radiology, the first people's Hospital of health No. 6 road 272100 in Shandong province Jining City Applicant after: Zhang Yong Address before: Shuibo 272699 Shandong County of Liangshan Province Road No. 82 Applicant before: Xu Daohui |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140430 Termination date: 20150322 |
|
| EXPY | Termination of patent right or utility model |